Cipla's InvaGen unit received a Form 483 with one observation after a cGMP inspection. Alembic Pharma gets tentative OK for generic Lynparza. Prestige Estates launches ₹12,000 crore projects.
Alpha Score of 45 reflects weak overall profile with weak momentum, poor value, strong quality, moderate sentiment.
Cipla's (NSE: CIPLA) InvaGen Pharmaceuticals subsidiary received a Form 483 with one observation after a U.S. Food and Drug Administration inspection at its Long Island, New York facility. The inspection ran from July 13 to 17 and was a routine current Good Manufacturing Practices check. Cipla said it will work closely with the FDA to address the observation.
The single observation doesn't signal a major compliance failure. It does add to the regulatory scrutiny Indian drugmakers face. Cipla shares could see pressure when trading opens.
Alembic Pharmaceuticals (NSE: APLLTD), through partner NATCO Pharma, received tentative FDA approval for Olaparib tablets. The drug is a generic version of AstraZeneca's Lynparza, used for cancer treatment. Alembic will distribute the product in the U.S. while NATCO manufactures it. AstraZeneca, which holds an Alpha Score of 48 on AlphaScala, now faces generic competition for Lynparza.
Prestige Estates Projects (NSE: PRESTIGE) launched three residential projects in the June quarter. The company estimated total revenue potential at ₹12,000 crore. The projects are in Hyderabad and Bengaluru, with a third in Mumbai. Prestige also launched a commercial project in Bengaluru with a developable area of 3 million square feet.
JSW Steel's (NSE: JSWSTEEL) board approved selling equity shares worth up to ₹811 crore in the proposed IPO of its subsidiary JSW One Platforms. The sale will be through an offer for sale.
Laser Power & Infra secured a ₹4.15 crore order from Himachal Pradesh State Electricity Board. The order involves replacing conventional conductors with advanced high-temperature low-sag conductors.
5paisa Capital partnered with OpenAI to integrate artificial intelligence into its investing and trading platform. The move brings personalized insights to retail investors.
CRISIL Ratings upgraded the long-term credit ratings of key Vedanta Group companies after the group's demerger. The agency assigned a Stable outlook, citing stronger standalone business profiles and improved financial flexibility.
NTPC's (NSE: NTPC) subsidiary THDC India commissioned an 11 MWac floating solar power plant on the raw water reservoir of the Khurja Super Thermal Power Project in Uttar Pradesh. The commissioning pushed NTPC Group's total installed capacity to 90,965 MW.
GAIL India (NSE: GAIL) signed an MoU with Khanij Bidesh India to collaborate on critical and strategic minerals. The partnership aims to strengthen India's long-term supply of these resources.
NBCC India (NSE: NBCC) moved forward with merging its wholly owned subsidiary HSCC India into itself. Since HSCC is entirely owned by NBCC, no new shares or cash will be exchanged.
Sterlite Technologies launched its pre-connectorized CONCAT fiber-to-the-home solution in the U.S. market. The company said the solution can reduce fiber deployment labor costs by up to 71%.
Navneet Education's subsidiary Navneet Learning agreed to sell a partial stake in K12 Techno Services to Kenro Capital for ₹329.68 crore. Kenro Capital is a specialist secondaries investment firm with over $100 million in AUM.
Avantel received a ₹20.81 crore purchase order from Larsen & Toubro for SATCOM products.
Samvardhana Motherson International (NSE: MOTHERSON) received court permission for its pending acquisition of Yutaka Giken. The transaction will give Motherson 81% voting-share ownership of YGCL and an 11% stake in a YGCL subsidiary.
Drafted by a large language model from the source reporting linked above, then screened by automated publishing checks. It is not read by a journalist before publication. Some articles cite our Alpha Score. Verify prices and figures against the original source. Educational coverage, not personalized advice.